Covered recipient · General Payments record
AIMEE L FLOURNOY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$2,808.70
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $158.47 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| IRONSHORE PHARMACEUTICALS INC. | $37.84 | 2 |
| Merck Sharp & Dohme Corporation | $21.39 | 1 |
| Abbott Laboratories | $19.45 | 1 |
| Lilly USA, LLC | $18.15 | 1 |
| ABBVIE INC. | $17.30 | 1 |
| Acerta Pharma LLC | $15.86 | 1 |
| Amgen Inc. | $14.39 | 1 |
| Novo Nordisk AS | $14.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.45 | 03/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018432347 | CMS |
| ABBVIE INC. | $17.30 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997262763 | CMS |
| Amgen Inc. | $14.39 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019778585 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.86 | 04/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015922565 | CMS |
| Ironshore Pharmaceuticals Inc. | $16.45 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060491223 | CMS |
| Ironshore Pharmaceuticals Inc. | $21.39 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060491067 | CMS |
| Lilly USA, LLC | $18.15 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031231303 | CMS |
| Merck Sharp & Dohme LLC | $21.39 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048749481 | CMS |
| Novo Nordisk Inc | $14.09 | 02/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001563431 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.